Purpose: To present clinical pharmacology of Sonovue (BRl) a new contrast medium (CM) for ultrasound imaging. Methods: Ninety-eight healthy volunteers in five single-or repeateddose phase I trials (two placebo-controlled). Sonovue doses from 0.003 (single) to 0.6 mlikg bw (cumulative of three consec
β¦ LIBER β¦
Ultrasound microbubble contrast angiography in monochorionic twin fetuses
β Scribed by Mark L Denbow; Martin JK Blomley; David O Cosgrove; Nicholas M Fisk
- Book ID
- 118562547
- Publisher
- The Lancet
- Year
- 1997
- Tongue
- English
- Weight
- 71 KB
- Volume
- 349
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
PIO 7707 The use of microbubble contrast
PIO 7707 The use of microbubble contrast angiography in monochorionic twin fetuses: Work in progress
β
M. Denbow; M. Blomley; D. Cosgrove; N. Fisk
π
Article
π
1997
π
Elsevier Science
π
English
β 143 KB
Transrectal ultrasound microbubble contr
β
Ragde, Haakon; Kenny, Gerald M.; Murphy, Gerald P.; Landin, Kent
π
Article
π
1997
π
John Wiley and Sons
π
English
β 664 KB
## BACKGROUND. Prostate cancer, suspected by serum prostate-specific antigen (PSA) elevation and/or digital abnormalities, is not always evident on gray-scale or color Doppler transrectal ultrasound (TRUS). EchoGen (Sonus Pharmaceuticals, Inc., Bothell, WA), a blood vessel image enhancer able to v
Microbubble contrastβenhanced ultrasound
π
Article
π
2004
π
Springer
π
English
β 362 KB
CO2 microbubble contrast enhancement in
β
Kariya, S.; Komemushi, A.; Nakatani, M.; Yoshida, R.; Sawada, S.; Tanigawa, N.
π
Article
π
2013
π
Elsevier Science
π
English
β 473 KB
Re: CO2 microbubble contrast enhancement
β
Patel, J.V.; Kessel, David
π
Article
π
2013
π
Elsevier Science
π
English
β 127 KB
Destruction of Contrast Agent Microbubbl
β
Klibanov, Alexander L; Hughes, Michael S; Wojdyla, Jolette K; Wible, James H; Br
π
Article
π
2002
π
Elsevier Science
π
English
β 490 KB